|4May 21, 3:55 PM ET

Gevo, Inc. 4

4 · Gevo, Inc. · Filed May 21, 2015

Insider Transaction Report

Form 4
Period: 2015-05-08
Transactions
  • Sale

    Common Stock

    2015-05-08$5.44/sh24,692$134,324111,429 total(indirect: By Malaysian Life Sciences Capital Fund)
  • Sale

    Common Stock

    2015-05-08$5.50/sh8,713$47,910102,716 total(indirect: By Malaysian Life Sciences Capital Fund)
Footnotes (2)
  • [F1]These securities are held by Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.
  • [F2]Additionally, the reporting person is the direct owner of 146,133 shares of common stock as previously reported on the Form 4 filed on July 1, 2014.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION